Akt Cancer Research Results
Akt, PKB-Protein kinase B: Click to Expand ⟱
| Source: HalifaxProj(inhibit) |
| Type: |
Akt1 is involved in cellular survival pathways, by inhibiting apoptotic processes; Akt2 is an important signaling molecule in the insulin signaling pathway. It is required to induce glucose transport.
Inhibitors:
-Curcumin: downregulate AKT phosphorylation and signaling.
-Resveratrol
-Quercetin: inhibit the PI3K/AKT pathway.
-Epigallocatechin Gallate (EGCG)
-Luteolin and Apigenin: inhibit AKT phosphorylation
|
Arthritis, Arthritis: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*other↝, *other↝, *CRP↓, *eff↝, *other↑, *CXCR4↓, *IL1β↓, *IL6↓, *IL17↓, *IL18↓, *TNF-α↓, *MMP9↓, *PGE2↓, *COX1↓, *COX2/PTGS2↓, *PI3K↓, *Akt↓, *other↑, TumCCA↑, Apoptosis↑, ROS↑, JNK↑, TumAuto↑, Hif1a↓, BNIP3↝, HSP90↓, Fas↑, FasL↑, ETC↓, VEGF↓, angioG↓, RadioS↑, *neuroP↑, *HSP70/HSPA5↑, *ROS↓, *MMP↑, *Cyt‑c↓, *Casp3↓, *Casp9↓, *MAPK↓, *Dose⇅, *HSPs↑, BioAv↓, Dose↝,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *hepatoP↑, *neuroP↑, *AntiCan↑, *toxicity↝, *BioAv↓, *HO-1↑, *NRF2↑, *NLRP3↑, *SOD↑, *SOD1↑, *ROS↓, *AntiAge↑, *ARE↑, *STAT↓, *NF-kB↓, *neuroG↑, *memory↑, ROS↑, NLRP3↑, CIP2A↓, Akt↓, STAT3↑, VEGFR2/KDR/Flk1↓, DNMTs↓, MAPK↓, YAP/TEAD↓, PI3K↓, Wnt↓, NOTCH↓, TumCCA↑, TumCG↓, TumCP↓, FAK↑, MMP9↓, TumAuto↑, toxicity↝, BioAv↓, Half-Life↝, BioAv↑, selectivity∅,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*diuretic↑, *Bacteria↓, *Inflam↓, AntiCan↑, TumCP↓, TumCI↓, angioG↓, *toxicity↓, IFN-γ↑, IL12↑, ROS↑, TNF-α↓, TNF-α↓, TGF-β↓, MAPK↓, PKCδ↓, NF-kB↓, HER2/EBBR2↓, VEGF↓, DNAdam↑, Necroptosis↑, Glycolysis↓, GLUT1↓, PI3K↓, Akt↓, Casp9↑, Casp3↑, BAX↑, Bcl-2↓, eff↑, MMP2↓, MMP9↓, eff↑, ChemoSen↑, P-gp/ABCB1↓, SREBP2↓, eff↑, *other↝, *COX2/PTGS2↓, *Hif1a↓, *HDAC↓, *tau↓, *PKCδ↑, *ROS↓, *Inflam↓, AntiAg?,
Apoptosis?, TumAuto↑, ROS↑, ATP↓, Glycolysis↓, PI3K↓, Akt↓, mTOR↓, *Apoptosis↓, *Inflam↓, *TNF-α↓, *IL6↓, *IL8↓, *IL10↓, *IL17↓, *hepatoP↑, *RenoP↑, PKM2↓, GLUT1↓, HK2↓,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 4,
Mitochondria & Bioenergetics(tgid=3) ⓘ
ATP↓, 1, ETC↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
Glycolysis↓, 2, HK2↓, 1, PKM2↓, 1, SREBP2↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 3, Apoptosis?, 1, Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 1, Casp3↑, 1, Casp9↑, 1, Fas↑, 1, FasL↑, 1, JNK↑, 1, MAPK↓, 2, Necroptosis↑, 1, YAP/TEAD↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
HER2/EBBR2↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP90↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
BNIP3↝, 1, TumAuto↑, 3,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, DNMTs↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CIP2A↓, 1, mTOR↓, 1, NOTCH↓, 1, PI3K↓, 3, STAT3↑, 1, TumCG↓, 1, Wnt↓, 1,
Migration(tgid=13) ⓘ
AntiAg?, 1, FAK↑, 1, MMP2↓, 1, MMP9↓, 2, PKCδ↓, 1, TGF-β↓, 1, TumCI↓, 1, TumCP↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 2, Hif1a↓, 1, VEGF↓, 2, VEGFR2/KDR/Flk1↓, 1,
Barriers & Transport(tgid=15) ⓘ
GLUT1↓, 2, P-gp/ABCB1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IFN-γ↑, 1, IL12↑, 1, NF-kB↓, 1, TNF-α↓, 2,
Protein Aggregation(tgid=19) ⓘ
NLRP3↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 2, BioAv↑, 1, ChemoSen↑, 1, Dose↝, 1, eff↑, 3, Half-Life↝, 1, RadioS↑, 1, selectivity∅, 1,
Clinical Biomarkers(tgid=22) ⓘ
HER2/EBBR2↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, toxicity↝, 1,
Total Targets: 64
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
diuretic↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, ARE↑, 1, HO-1↑, 1, NRF2↑, 1, ROS↓, 3, SOD↑, 1, SOD1↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↑, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Apoptosis↓, 1, Casp3↓, 1, Casp9↓, 1, Cyt‑c↓, 1, MAPK↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
other↑, 2, other↝, 3,
Protein Folding & ER Stress(tgid=8) ⓘ
HSP70/HSPA5↑, 1, HSPs↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
HDAC↓, 1, neuroG↑, 1, PI3K↓, 1, STAT↓, 1,
Migration(tgid=13) ⓘ
MMP9↓, 1, PKCδ↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
Hif1a↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX1↓, 1, COX2/PTGS2↓, 2, CRP↓, 1, CXCR4↓, 1, IL10↓, 1, IL17↓, 2, IL18↓, 1, IL1β↓, 1, IL6↓, 2, IL8↓, 1, Inflam↓, 4, NF-kB↓, 1, PGE2↓, 1, TNF-α↓, 2,
Synaptic & Neurotransmission(tgid=18) ⓘ
tau↓, 1,
Protein Aggregation(tgid=19) ⓘ
NLRP3↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, Dose⇅, 1, eff↝, 1,
Clinical Biomarkers(tgid=22) ⓘ
CRP↓, 1, IL6↓, 2,
Functional Outcomes(tgid=23) ⓘ
AntiAge↑, 1, AntiCan↑, 1, hepatoP↑, 2, memory↑, 1, neuroP↑, 2, RenoP↑, 1, toxicity↓, 1, toxicity↝, 1,
Infection & Microbiome(tgid=24) ⓘ
Bacteria↓, 1,
Total Targets: 56
Scientific Paper Hit Count for: Akt, PKB-Protein kinase B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:35 Cells:% prod#:% Target#:4 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page